Discipline of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Adelaide, SA, Adelaide, Australia.
Department of Clinical Pharmacology, Flinders Medical Centre, Southern Adelaide Local Health Network, Adelaide, SA, Adelaide, Australia.
Front Immunol. 2024 Aug 21;15:1438302. doi: 10.3389/fimmu.2024.1438302. eCollection 2024.
Patients with systemic sclerosis (SSc) have an increased risk of endothelial dysfunction, atherosclerosis, and cardiovascular events compared to the general population. Therefore, the availability of robust circulating biomarkers of endothelial dysfunction and atherogenesis may facilitate early recognition and management of cardiovascular risk in SSc. We sought to address this issue by conducting a systematic review and meta-analysis of studies investigating various types of circulating cell adhesion molecules involved in endothelial dysfunction and atherogenesis (i.e., immunoglobulin-like vascular cell, VCAM-1, intercellular, ICAM-1, platelet endothelial cell, PECAM-1, neural cell, NCAM, Down syndrome cell, DSCAM, and endothelial cell-selective, ESAM, adhesion molecules, E-, L-, and P-selectin, integrins, and cadherins) in SSc patients and healthy controls.
We searched PubMed, Scopus, and Web of Science from inception to 1 May 2024. Risk of bias and certainty of evidence were assessed using validated tools.
In 43 eligible studies, compared to controls, patients with SSc had significantly higher plasma or serum concentrations of ICAM-1 (standard mean difference, SMD=1.16, 95% CI 0.88 to 1.44, p<0.001; moderate certainty), VCAM-1 (SMD=1.09, 95% CI 0.72 to 1.46, p<0.001; moderate certainty), PECAM-1 (SMD=1.65, 95% CI 0.33 to 2.98, p=0.014; very low certainty), E-selectin (SMD=1.17, 95% CI 0.72 to 1.62, p<0.001; moderate certainty), and P-selectin (SMD=1.10, 95% CI 0.31 to 1.90, p=0.007; low certainty). There were no significant between-group differences in L-selectin concentrations (SMD=-0.35, 95% CI -1.03 to 0.32, p=0.31; very low certainty), whereas minimal/no evidence was available for cadherins, NCAM, DSCAM, ESAM, or integrins. Overall, no significant associations were observed between the effect size and various patient and study characteristics in meta-regression and subgroup analyses.
The results of this systematic review and meta-analysis suggest that specific circulating cell adhesion molecules, i.e., ICAM-1, VCAM-1, PECAM-1, E-selectin, and P-selectin, can be helpful as biomarkers of endothelial dysfunction and atherogenesis in the assessment of cardiovascular risk in SSc patients.
https://www.crd.york.ac.uk/prospero/, identifier CRD42024549710.
与普通人群相比,系统性硬化症(SSc)患者存在内皮功能障碍、动脉粥样硬化和心血管事件的风险增加。因此,能够发现稳健的内皮功能障碍和动脉粥样形成的循环生物标志物,可能有助于早期识别和管理 SSc 的心血管风险。我们通过对研究各种参与内皮功能障碍和动脉粥样形成的循环细胞黏附分子(即免疫球蛋白样血管细胞黏附分子 [VCAM-1]、细胞间黏附分子 [ICAM-1]、血小板内皮细胞黏附分子 [PECAM-1]、神经细胞黏附分子 [NCAM]、唐氏综合征细胞黏附分子 [DSCAM]、内皮细胞选择性黏附分子 [ESAM]、E-、L- 和 P-选择素、整合素和钙黏蛋白)的研究进行系统回顾和荟萃分析,来解决这个问题。这些研究涉及 SSc 患者和健康对照组。
我们从成立到 2024 年 5 月 1 日在 PubMed、Scopus 和 Web of Science 进行了检索。使用经过验证的工具评估风险偏倚和证据确定性。
在 43 项符合条件的研究中,与对照组相比,SSc 患者的血浆或血清 ICAM-1(标准均数差 [SMD]=1.16,95%置信区间 [CI] 0.88 至 1.44,p<0.001;中等确定性)、VCAM-1(SMD=1.09,95% CI 0.72 至 1.46,p<0.001;中等确定性)、PECAM-1(SMD=1.65,95% CI 0.33 至 2.98,p=0.014;极低确定性)、E-选择素(SMD=1.17,95% CI 0.72 至 1.62,p<0.001;中等确定性)和 P-选择素(SMD=1.10,95% CI 0.31 至 1.90,p=0.007;低确定性)浓度显著更高。在 L-选择素浓度(SMD=-0.35,95% CI -1.03 至 0.32,p=0.31;极低确定性)方面,两组间无显著差异,而钙黏蛋白、NCAM、DSCAM、ESAM 或整合素的证据很少或没有。总体而言,在荟萃回归和亚组分析中,未观察到效应大小与各种患者和研究特征之间存在显著关联。
这项系统评价和荟萃分析的结果表明,特定的循环细胞黏附分子,即 ICAM-1、VCAM-1、PECAM-1、E-选择素和 P-选择素,可作为 SSc 患者内皮功能障碍和动脉粥样形成的生物标志物,有助于评估心血管风险。
https://www.crd.york.ac.uk/prospero/,标识符 CRD42024549710。